NCT00223548View on ClinicalTrials.gov

MESNA for Prevention of Acute Deterioration of Renal Function Following Contrast Agent Application

PHASE2CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

October 31, 2002

Study Completion Date

December 31, 2004

Conditions
Chronic Renal InsufficiencySerum Creatinine ConcentrationContrast Media Exposition
Interventions
DRUG

sodium 2-mercaptoethane sulfonate

Trial Locations (1)

89081

Division of Nephrology, University of Ulm, Ulm

All Listed Sponsors
lead

University of Ulm

OTHER

NCT00223548 - MESNA for Prevention of Acute Deterioration of Renal Function Following Contrast Agent Application | Biotech Hunter | Biotech Hunter